Eli Lilly (Mexico) Buy Hold or Sell Recommendation

LLY Stock  MXN 12,919  43.05  0.33%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Eli Lilly And is 'Strong Sell'. Macroaxis provides Eli Lilly buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LLY positions. The advice algorithm takes into account all of Eli Lilly's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Eli Lilly's buy or sell advice are summarized below:
Real Value
10.4 K
Hype Value
12.9 K
Market Value
12.9 K
Naive Value
13.7 K
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Eli Lilly And given historical horizon and risk tolerance towards Eli Lilly. When Macroaxis issues a 'buy' or 'sell' recommendation for Eli Lilly And, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Eli Lilly Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Eli and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute Eli Lilly Buy or Sell Advice

The Eli recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eli Lilly And. Macroaxis does not own or have any residual interests in Eli Lilly And or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eli Lilly's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Eli LillyBuy Eli Lilly
Strong Sell

Market Performance

SolidDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves slightly opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Eli Lilly And has a Mean Deviation of 1.58, Semi Deviation of 1.62, Standard Deviation of 2.14, Variance of 4.58, Downside Variance of 5.96 and Semi Variance of 2.63
Macroaxis provides advice on Eli Lilly And to complement and cross-verify current analyst consensus on Eli Lilly And. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Eli Lilly is not overpriced, please confirm all Eli Lilly And fundamentals, including its shares owned by institutions, ebitda, current ratio, as well as the relationship between the price to sales and cash per share .

Eli Lilly Trading Alerts and Improvement Suggestions

Eli Lilly And has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 85.0% of the company shares are owned by institutional investors

Eli Lilly Returns Distribution Density

The distribution of Eli Lilly's historical returns is an attempt to chart the uncertainty of Eli Lilly's future price movements. The chart of the probability distribution of Eli Lilly daily returns describes the distribution of returns around its average expected value. We use Eli Lilly And price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eli Lilly returns is essential to provide solid investment advice for Eli Lilly.
Mean Return
0.42
Value At Risk
-3.73
Potential Upside
4.08
Standard Deviation
2.14
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eli Lilly historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Eli Lilly Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Eli Lilly or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Eli Lilly's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Eli stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.51
β
Beta against NYSE Composite-0.79
σ
Overall volatility
2.18
Ir
Information ratio 0.14

Eli Lilly Volatility Alert

Eli Lilly And currently demonstrates below-average downside deviation. It has Information Ratio of 0.14 and Jensen Alpha of 0.51. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Eli Lilly's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Eli Lilly's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Eli Lilly Fundamentals Vs Peers

Comparing Eli Lilly's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eli Lilly's direct or indirect competition across all of the common fundamentals between Eli Lilly and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eli Lilly or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Eli Lilly's fundamental indicators could also be used in its relative valuation, which is a method of valuing Eli Lilly by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Eli Lilly to competition
FundamentalsEli LillyPeer Average
Return On Equity0.65-0.31
Return On Asset0.11-0.14
Profit Margin0.22 %(1.27) %
Operating Margin0.29 %(5.51) %
Current Valuation6.99 T16.62 B
Shares Outstanding950.18 M571.82 M
Shares Owned By Insiders0.15 %10.09 %
Shares Owned By Institutions85.00 %39.21 %
Price To Earning333.06 X28.72 X
Price To Book34.76 X9.51 X
Price To Sales231.96 X11.42 X
Revenue28.54 B9.43 B
Gross Profit21.91 B27.38 B
EBITDA8.28 B3.9 B
Net Income6.24 B570.98 M
Cash And Equivalents2.2 B2.7 B
Cash Per Share2.39 X5.01 X
Total Debt15.35 B5.32 B
Debt To Equity648.20 %48.70 %
Current Ratio1.12 X2.16 X
Book Value Per Share11.19 X1.93 K
Cash Flow From Operations7.26 B971.22 M
Earnings Per Share123.49 X3.12 X
Price To Earnings To Growth2.23 X4.89 X
Number Of Employees4718.84 K
Beta0.35-0.15
Market Capitalization6.16 T19.03 B
Total Asset48.81 B29.47 B
Annual Yield0.01 %
Five Year Return2.46 %
Net Asset48.81 B
Last Dividend Paid3.92

Eli Lilly Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Eli . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Eli Lilly Buy or Sell Advice

When is the right time to buy or sell Eli Lilly And? Buying financial instruments such as Eli Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Eli Lilly in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate ETFs Thematic Idea Now

Real Estate ETFs
Real Estate ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Eli Lilly Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.